An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 959-968

  Simpson, Natalie E ^a   Tryndyak, Volodymyr P ^a   Beland, Frederick A ^a   Pogribny, Igor P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomarkers; Breast cancer; Epigenetics; Glutamine metabolism; Histone acetylation

Indexed keywords

AGENTS AFFECTING METABOLISM; COMPOUND 968; GLUTAMIC ACID; GLUTAMINE; HISTONE H3; HISTONE H4; MOLECULAR MARKER; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; EPIGENETICS; EPITHELIUM CELL; GENE; GENE EXPRESSION; GFPT2 GENE; GLS1 GENE; HDAC9 GENE; HISTONE ACETYLATION; HISTONE METHYLATION; LDHA GENE; MESENCHYME CELL; MYST2 GENE; PRIORITY JOURNAL; SUV420H2 GENE;

EID: 85027956114     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/S10549-011-1871-X     Document Type: Article

References (50)

1. Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. Easton DF et al (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 52(4):678-701
3. Nanda R (2007) Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions. Rev Recent Clin Trials 2(2): 111-116
4. Sparano JA, Paik S (2008) Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26(5):721-728
5. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
6. Trimboli AT et al (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68(3):937-945
7. Birchmeier W, Behrens J (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198(1): 11-26
8. Thomson S et al (2005) Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65 (20):9455-9462
9. Kashiwagi S et al (2010) Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103 (2):249-255
10. Giunciuglio D et al (1995) Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 63(6):815-822
11. Gilles C et al (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sei 112(24):4615-1625
12. Kim HJ et al (2007) Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 27(8):3165-3175
13. Chua HL et al (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26(5):711-724
14. Hinsheiwood RA, Clark S J (2008) Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Mol Med 86(12):1315-1328
15. Dworkin AM, Huang TH, Toland AE (2009) Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 19(3): 165-171
16. McCormick F (2001) Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 1(2):130-141
17. Ellis L, Atadja PW, Johnstone RW (2009) Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 8(6): 1409-1420
18. Burgio G, Onorati MC, Corona DF (2010) Chromatin remodeling regulation by small molecules and metabolites. Biochim Biophys Acta 1799(10-12):671-680
19. Teperino R, Schoonjans K, Auwerx J (2010) Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab 12(4):321-327
20. Wellen KE et al (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324(5930): 1076-1080
21. Gao Z, Xu CW (2011) Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells. Biochem Biophys Res Commun 404(1):428-133
22. Klose RJ, Kallin EM, Zhang Y (2006) JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7(9):715-727
23. Wang JB et al (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18(3):207-219
24. Li vak KT, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408
25. Choi YL et al (2010) LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Res 70(6):2296-2306
26. Bhattacharya S, Mariani TJ (2009) Array of hope: expression profiling identifies disease biomarkers and mechanism. Biochem Soc Trans 37(Pt 4):855-862
27. Richardson AD et al (2008) Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res Treat 110(2):297-307
28. Pétrie K et al (2003) The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 278(18): 16059-16072
29. Tao R et al (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13(11):1299-1307
30. Taipale M et al (2005) hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol 25(15):6798-6810
31. Schotta G et al (2004) A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18(11):1251-1262
32. Secombe J et al (2007) The trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21(5):537-551
33. Tryndyak VP, Kovalchuk O, Pogribny IP (2006) Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransf erase and methyl-binding proteins. Cancer Biol Ther 5(1):65-70
34. Michishita E et al (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452(7186):492-496
35. Schwer B et al (2010) Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sei USA 107(50):21790-21794
36. Mao Z et al (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science 332(6036): 1443-1446
37. DeBerardinis RJ et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sei USA 104(49): 19345-19350
38. Elsheikh SE et al (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69(9):3802-3809
39. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358(11): 1148-1159
40. Seligson DB et al (2009) Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 174(5):1619-1628
41. Kurdistani SK (2011) Histone modifications in cancer biology and prognosis. Prog Drug Res 67:91-106
42. Moreno DA et al (2010) Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol 150(6):665-673
43. Milde T et al (2010) HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 16(12):3240-3252
44. Wang WZ et al (2010) Estrogen receptor alpha (ERalpha) mediates 17beta-estradiol (E2)-activated expression of HBOl. J Exp Clin Cancer Res 29:140
45. Goldman RD, Kaplan NO, Hall TC (1964) Lactic dehydrogenase in human neoplastic tissues. Cancer Res 24:389-399
46. Warburg O (1925) Über den Stoffwechsel der Carcinomzelle. Klin Wochenschr Berl 4:534-536
47. Le A et al (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sei USA 107(5):2037-2042
48. Asiago VM et al (2010) Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 70(21):8309-8318
49. Kapoor-Vazirani P, Kagey JD, Vertino PM (2011) SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation. Mol Cell Biol 31(8):1594-1609
50. Wysocka J et al (2006) A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098):86-90